Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

By Becker C.   Piironen T.   Pettersson K.   Hugosson J.   Lilja H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 694-699

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite

Serum free and total prostate-specific antigen levels in patients with liver disease - establishment of age-specific ranges

By Kilic S.   Guntekin E.   Danisman A.   Kukul E.   Suleymanlar I.   Sevuk M.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 825-827

Elsevier

Access to resources Recommend Favorite

Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free:total PSA ratios in a consecutive series of men referred for prostate biopsies

By Rydén Linda   Egevad Lars   Ekman Peter   Hellström Magnus  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 302-307

Informa Healthcare

Access to resources Recommend Favorite

Effect of ejaculation on serum total and free prostate-specific antigen concentrations

By Herschman J.D.   Smith D.S.   Catalona W.J.  

Urology, Vol. 50, Iss. 2, 1997-08 ,pp. : 239-243

Elsevier

Access to resources Recommend Favorite